Scholarlink

<p>Neuronal death triggered by hypoxia-ischemia (HI) is a major cause of neonatal mortality and long-term neurological deficits. Excessive autophagy plays a pathogenic role in neonatal hypoxic-ischemic encephalopathy (HIE), and inhibition of phosphatase and tensin homolog deleted on chromosome TEN (PTEN) nuclear translocation has been shown to suppress autophagy. Our recent study demonstrated that blocking PTEN nuclear import with the peptide Tat-K13 mitigates HI-induced behavioral impairments. However, the underlying mechanism remains unclear. Here, we found that HI activated the p-JUN–SESN2–AMPK signaling pathway in both <i>in vivo </i>and <i>in vitro</i> models of neonatal hypoxic-ischemic brain damage (HIBD). Downregulation of JUN reduced neuronal loss and improved behavioral outcomes in HIBD rats. Furthermore, Tat-K13-mediated blockade of PTEN nuclear translocation attenuated HI-induced activation of the p-JUN–SESN2–AMPK pathway and suppressed autophagy. Notably, the neuroprotective and behavioral benefits conferred by Tat-K13 were achieved through autophagy inhibition resulting from suppression of this signaling cascade. These findings identify targeting PTEN nuclear import with Tat-K13 as a potential therapeutic strategy for neonatal HIE, acting via the p-JUN–SESN2–AMPK-autophagy axis to promote neuronal survival and functional recovery.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Inhibition of PTEN nuclear translocation by peptide Tat-K13 attenuates p-JUN–SESN2–AMPK-dependent autophagy and enhances neurological recovery after neonatal hypoxic-ischemic brain damage

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月29日

查看全文
  • Chunfang Dai,
  • Xiaobin Wu,
  • Xiaohuan Li,
  • Boqing Xu,
  • Yayan Pang,
  • Yunyun Huang,
  • Xiangjun Dong,
  • Nianrong Wang,
  • Zhifang Dong

摘要

Neuronal death triggered by hypoxia-ischemia (HI) is a major cause of neonatal mortality and long-term neurological deficits. Excessive autophagy plays a pathogenic role in neonatal hypoxic-ischemic encephalopathy (HIE), and inhibition of phosphatase and tensin homolog deleted on chromosome TEN (PTEN) nuclear translocation has been shown to suppress autophagy. Our recent study demonstrated that blocking PTEN nuclear import with the peptide Tat-K13 mitigates HI-induced behavioral impairments. However, the underlying mechanism remains unclear. Here, we found that HI activated the p-JUN–SESN2–AMPK signaling pathway in both in vivo and in vitro models of neonatal hypoxic-ischemic brain damage (HIBD). Downregulation of JUN reduced neuronal loss and improved behavioral outcomes in HIBD rats. Furthermore, Tat-K13-mediated blockade of PTEN nuclear translocation attenuated HI-induced activation of the p-JUN–SESN2–AMPK pathway and suppressed autophagy. Notably, the neuroprotective and behavioral benefits conferred by Tat-K13 were achieved through autophagy inhibition resulting from suppression of this signaling cascade. These findings identify targeting PTEN nuclear import with Tat-K13 as a potential therapeutic strategy for neonatal HIE, acting via the p-JUN–SESN2–AMPK-autophagy axis to promote neuronal survival and functional recovery.